NIH AI Restriction
NIH policy NOT-OD-25-132 prohibits the use of AI-generated text in grant applications that is not substantially modified by the applicant. All AI-drafted sections must be thoroughly rewritten in your own words before submission.
View full policyTargeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01)
About This Grant
-Purpose. This Funding Opportunity Announcement (FOA) issued by the National Heart, Lung, and Blood Institute (NHLBI), National Institutes of Health (NIH), solicits grant applications from institutions/organizations that propose to exploit present knowledge of Ca2+ regulatory molecules and the role they play in arrhythmogenesis to develop novel therapeutic targets. Critical components of successful responses to this program announcement are (1) preclinical or early clinical testing of promising new therapeutic strategies to terminate and prevent cardiac arrhythmias in established models of human arrhythmogenic disease, and (2) the feasibility to move positive findings to Phase l or ll clinical trials. -Mechanism of Support. This FOA will utilize the NIH Research Project Grant (R01) award mechanism. -Funds Available and Anticipated Number of Awards. Because the nature and scope of the proposed research will vary from application to application, it is anticipated that the size and duration of each award will also vary. The total amount awarded and the number of awards will depend upon the mechanism numbers, quality, duration, and costs of the applications received.
Grant Summary
Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01) is a National Institutes of Health grant providing funding that varies by award for municipality. Applications are accepted on a rolling basis. Check eligibility and apply with FindGrants.
Focus Areas
Eligibility
How to Apply
Up to $0K
Rolling / Open
- 1Confirm your organization is eligible for Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01) from National Institutes of Health, checking organization type, location, and any population or project requirements.
- 2Gather the required documents and information, including your organization details, project plan, and budget figures.
- 3Draft your application narrative and budget addressing the funder's priorities and review criteria. FindGrants can draft each section for you to review and edit.
- 4Review every section against the requirements checklist, then export a submission-ready application pack and submit it to National Institutes of Health before the deadline.
Search & build free — $99 one-time to unlock the export-ready application pack. No subscription.
Don't want to draft it yourself?
We'll draft the complete application against National Institutes of Health's requirements, run a quality review, and email you a submission-ready PDF plus an editable Word doc within 5 business days. Most orders deliver in 24-48 hours. Flat $399, any grant size.
AI Requirement Analysis
Detailed requirements not yet analyzed
Have the NOFO? Paste it below for AI-powered requirement analysis.
Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01): Frequently Asked Questions
Who is eligible for the Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01)?
Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01) is offered by National Institutes of Health and is generally open to municipality. It is open to organizations nationwide unless the funder specifies otherwise. Review the specific eligibility terms before applying, since funders set their own requirements around organization type, location, and the population or project being served.
How much funding does the Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01) provide?
Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01) provides an amount that varies by award per award from National Institutes of Health. Actual award sizes depend on the scope of your project, available program funds, and the number of applicants, so build a budget that reflects realistic, allowable costs rather than the maximum figure.
When is the Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01) deadline?
Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01) accepts applications on a rolling or ongoing basis, so there is no single fixed deadline. Confirm current timing with the funder, National Institutes of Health, before you apply, and submit as early as possible because rolling programs can close once funds are committed.
How do you apply for the Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01)?
To apply for Targeting Calcium Regulatory Molecules for Arrhythmia Prevention (R01), confirm your eligibility, gather the required documents, and prepare a narrative and budget that address the funder's priorities. FindGrants guides you step by step and can draft each section, then exports a submission-ready application pack for this grant from National Institutes of Health.